Jonathan Reed Health Editor

Recess Beer Garden Pulls Plug on Unjected Mixer

The dating platform Unjected has been forced to relocate its May 29 singles mixer after the Recess Beer Garden withdrew from the event. The app, which caters exclusively to unvaccinated individuals, will now hold the gathering at the Grizzly Rose on the original date.

Safety Concerns and Venue Policy

The cancellation at the Denver venue followed days of public backlash. In a May 13 release, the Recess Beer Garden stated the event was scrapped because organizers failed to comply with policies governing large gatherings.

Beyond administrative issues, the Highland neighborhood establishment reported significant security concerns. Staff members faced harassment and the business received direct threats. Catherine Tiner, the venue’s director of marketing, clarified on May 12 that the beer garden did not organize, sponsor, or formally host the meetup.

Hostility and Accusations of Discrimination

Shelby Hosana, the Hawaii-based founder who launched the platform in 2021, voiced her frustration with the decision. She claimed the venue’s explanation was a calculated attempt to mask discriminatory practices.

“We just wanted to have a peaceful gathering, and we were denied like second-class citizens,” Hosana said.

The platform responded aggressively on social media. In an Instagram story, the organization accused the beer garden of having “bent over to the woke mob” and characterized their critics as “vaccine cultists.”

Digital Backlash and Real-World Relocation

The dispute ignited a firestorm of online activity. The venue’s social media pages and review sites were flooded with negative feedback, including one-star Yelp reviews that labeled the establishment as “disgustingly woke.”

On May 14, Unjected confirmed that its “Freedom Mixer” would shift to the Grizzly Rose, a country-music club in Denver. The event remains scheduled for May 29, marking another stop in the platform’s multi-state tour.

Building Community Through Shared Values

Unjected frames itself as a social hub for those seeking “health-conscious relationships.” The app utilizes a matching algorithm based on shared values and allows users to connect via voice and video calls.

According to the company, the platform serves as a space for users to find partners and friends who hold similar views on vaccination. Many members have shared testimonials detailing their experiences finding community through the service.

Consult your healthcare provider for medical questions regarding vaccines or health decisions.

Find more reporting in our Health section.

Why the Study Was Retracted: Key Concerns

The retracted study, published earlier this year in Nature Medicine, reported that lung cancer patients treated with immunotherapy in the morning showed a “massive reduction” in disease progression risk compared to those treated in the afternoon. However, multiple scientists and data sleuths flagged inconsistencies in the trial’s results, casting doubt on its biological plausibility. STAT News reported that the journal appended a note acknowledging an investigation into the concerns, while LinkedIn highlighted that editors cited “inconsistencies raised in the web” as the reason for the retraction.

Critics questioned whether the study’s findings were statistically robust or whether the observed effects were merely coincidental. Some researchers suggested the apparent time-of-day effect might stem from unmeasured confounding factors, such as patient circadian rhythms or variations in staff protocols between morning and afternoon shifts. The retraction underscores a broader issue in oncology: how easily flawed but compelling studies can influence clinical practice before being debunked.

Broader Implications: Peer Review Under Fire

The retraction raises urgent questions about the peer-review process in medical journals. LinkedIn noted that the study’s flaws might have been caught earlier if journals relied more on paid, professional reviewers rather than unpaid academic volunteers. The post cited a Science Magazine analysis by Laura Agudelo, which argued that the volume of submissions has outpaced the capacity of volunteer reviewers, leading to gaps in scrutiny.

According to STAT News, experts warned that the study’s conclusions lacked strong biological plausibility from the outset. Immunotherapy’s mechanism—boosting the immune system to attack cancer—does not inherently depend on the time of day. Yet the study’s dramatic findings led some physicians to adjust their schedules, assuming the data was sound. The retraction now forces a reckoning: how many other studies with similar flaws have slipped through, and what does this mean for patient care?

What Happens Next: The Road Ahead for Oncology Research

The retraction does not mean time-of-day effects on immunotherapy are definitively ruled out. But it does eliminate the most cited evidence supporting the idea. Moving forward, researchers will need to design rigorous studies that control for confounding variables—such as patient circadian rhythms, staff experience, or even environmental factors like lighting—to determine whether timing truly matters. LinkedIn emphasized that the episode highlights the “cost of scientific integrity,” warning against rushing to adopt new protocols based on preliminary or flawed data.

For oncologists, the retraction serves as a cautionary tale. It reminds them to wait for confirmatory evidence before altering clinical practice—especially when the stakes involve patient outcomes. Meanwhile, journals may face pressure to reform peer review, ensuring that studies with questionable data are caught before they gain traction. The episode also raises ethical questions: how many physicians may have already changed their practice based on the retracted findings, and how do they now adjust?

A Timeline of the Study’s Rise and Fall

• Early 2026: Study published in Nature Medicine, claiming morning immunotherapy infusions significantly reduce lung cancer progression risk.
• February 2026: Scientists and data sleuths begin raising concerns about inconsistencies in the trial’s results.
• Mid-February 2026: Nature Medicine appends a note acknowledging an investigation into the concerns.
• June 2026: Journal retracts the study after losing confidence in its data integrity.

The retraction comes at a time when immunotherapy remains a cornerstone of cancer treatment. While the study’s findings were never universally accepted, its retraction eliminates the most prominent evidence suggesting timing matters. Oncologists and researchers will now turn to other avenues—such as circadian biology studies—to explore whether time-of-day effects exist at all. For patients, the message is clear: clinical decisions should be based on the most robust, verified evidence available.

For now, the retraction serves as a reminder of the fragility of medical science—and the importance of skepticism in an era where bold claims can spread rapidly, even when they lack solid backing.

Find more reporting in our Health section.